The results from the present study demonstrate that the innate defense mechanisms which control the progressive growth of Listeria monocytogenes in normal animals in vivo are dependent upon the active catabolism of endogenous glucocorticoids by the enzyme 11β-hydroxysteroid dehydrogenase (11β-HSD). When 11β-HSD activity was pharmacologically inhibited in vivo, host susceptibility to progressive bacterial disease was markedly increased. Depressed natural resistance following 11β-HSD inhibition correlated with changes in the patterns of inducible cytokines by macrophages and T cells. Similar changes were observed when normal adult animals were treated with low doses of dexamethasone prior to experimental infection with Listeria.
Introduction
The cytokines produced by activated T lymphocytes and CD8 ϩ T cell effector activities (5). Cellular components of the innate immune system, specifically macrophages and NK macrophages impart regulatory influences over the development and nature of subsequently generated immune and cells, play essential roles to limit the spread of Listeria, as demonstrated by in vivo studies utilizing SCID mice (6). To inflammatory responses. It is now recognized that the specific species of cytokines produced following an experimental achieve total clearance of bacteria from the host, however, requires the induction and activities of antigen-specific CD4 ϩ challenge with an infectious agent can significantly influence host resistance or susceptibility to disease (1) . Host resistance and CD8 ϩ T cells (5). The ability of infected mice to effectively control Listeria to many intracellular pathogens, including Leishmania sp., Mycobacterium sp. and Listeria monocytogenes, requires the requires the bioactivities of several cytokines including tumor necrosis factor (TNF)-α, IL-6, IL-12 and IFN-γ (6,7). The induction of a predominant type 1 immune response which is phenotypically characterized by induced production of ILactivation of macrophages by Listeria results in the secretion of TNF-α, IL-6 and IL-12 (7-9). The TNF-α and IL-12 can act 2, IFN-γ and IL-12 (2-4). Conversely, an enhanced host susceptibility to disease by these infectious agents has been synergistically on NK cells to induce the synthesis of IFN-γ which, in turn, enhances Listeria antigen presentation to linked with the induced production of IL-4, IL-10 and IL-13 following infection (1) . macrophages and augments their microbicidal mechanisms (6,9). IFN-γ can itself induce the synthesis of nitric oxide, L. monocytogenes represents a prototypical intracellular microbial pathogen. Following a challenge of immunocompewhich is inhibitory to Listeria growth, by up-regulating nitric oxide synthase (iNOS) (10, 11) . Inhibition of either of the IFNtent mice with this infectious agent, disease resolution normally takes place subsequent to the activation of host macrophages, γ inducing cytokines (IL-12 or TNF-α) or IFN-γ itself in vivo results in uncontrolled bacterial growth (6,8,12). followed by the antigen-specific involvement of CD4 ϩ and Steroid hormones, especially the glucocorticoids (GCS), cing their ability to produce the type 2 cytokines. It was additionally demonstrated that the 11β-HSD associated with are well known modulators of immune responses in vitro and in vivo (13) . Conditions which elevate GCS are capable of secondary lymphoid organs possessed characteristics which were distinct from either of the other two cloned 11β-HSD influencing many processes important in innate and acquired immunity to Listeria, thereby enhancing host susceptibility to isoforms (29, 30) . This finding suggests that the lymphoid organ stromal cell enzyme may represent a novel 11β-HSD infection with this microorganism (14) . There exists a number of possibilities to explain the immunomodulatory activities of isoform (23) . A very recent report provides evidence for a third 11β-HSD isoform. The 11β-HSD in the choriocarcinoma GCS on mammalian anti-microbial defense mechanisms. GCS are known to directly inhibit macrophage production of the cell line JEG-3 was distinct in enzymatic properties from the two previously cloned enzymes but was similar in characterinflammatory cytokines TNF-α, IL-1 and IL-6 following cellular activation (15-17). GCS can also depress the production of istics to the lymphoid organ enzyme (31) . We demonstrate in the present study that the inhibition of IFN-γ and the expression of iNOS (18, 19) . It has also been demonstrated that GCS possess the capacity to enhance endogenous 11β-HSD activity in vivo greatly enhances the susceptibility of animals to progressive disease following an cellular production of active transforming growth factor-β, lipocortin-1, and the type 2 cytokines IL-4 and IL- 10 (20-24) .
infection with Listeria organisms. Enhanced susceptibility to disease could be correlated with depressions in the ability of The ability of GCS to increase susceptibility to infection may therefore be, in part, due to the enhanced expression of Listeria-activated lymphoid cells from these animals to produce IFN-γ, TNF-α and IL-6 with a parallel increase in their various anti-inflammatory cytokines since the administration of IL-10 to SCID or normal immunocompetent animals inhibits production of IL-10. Our results suggest that endogenous GCS have the potential to exert significant immunoregulatory innate resistance to Listeria infection (25) . This appears to be due to the suppressive effects of IL-10 on the production of activities and that the normal tissue-associated catabolism of GCS by 11β-HSD plays an important role in regulating the TNF-α, IFN-γ and possibly IL-12 (9). These studies indicate that elevated tissue levels of GCS, either endogenously or effects of these steroids on immune function in vivo. exogenously, can impart regulatory control over the progression of a Listeria infection by altering the expression of those Methods cytokines which directly influence disease outcome (TNF-α, IL-12, IFN-γ versus IL-10). Animals There are numerous mechanisms which operate in vivo Female C3H/HeN MTV -and C57BL/6 mice were purchased to control specific tissue levels of endogenous GCS. The from the National Cancer Institute (NIH, Bethesda, MD). regulation of adrenal GCS biosynthesis represents one way Animals were housed at the University of Utah Animal that circulating steroid concentrations are controlled in vivo Resource Center. The Institutional Animal Resource Center at (26) . It has also been demonstrated that variations in tissue the University of Utah guarantees strict compliance with the expression of the intracellular enzyme 11β-hydroxysteroid regulations established by the Animal Welfare Act. dehydrogenase (11β-HSD) can effectively regulate tissuespecific corticosteroid levels. This enzyme has the ability to Materials interconvert biologically active 11-hydroxy GCS (cortisol and Glycyrrhetinic acid (GA), corticosterone and 11-dehydrocorticosterone) with their inactive 11-keto metabolites (cortiscorticosterone were purchased from Sigma (St Louis, MO). one and 11-dehydrocorticosterone respectively) (27) . 11β-The hybridoma secreting anti-CD3ε antibody (145 2C) was HSD activity is critical for the proper function of several distinct kindly provided by J. Bluestone (University of Chicago, IL). organ systems in the body including the kidney and the All antibodies used for cytokine quantification were purchased testes, where GCS can have detrimental effects on normal from PharMingen (San Diego, CA). RU486 and placebo physiological processes (27) . Additionally, 11β-HSD is importpellets were obtained from Innovative Research (Toledo, OH). ant in fetal development as this enzyme activity protects the Placebo or RU486 pellets were implanted into anesthetized fetus from the growth inhibitory activities associated with animals by making small incisions on the abdomen and chronic GCS exposure (28) .
inserting the pellet directly under the skin. The incision was We have recently demonstrated that distinct secondary closed with a surgical staple. Each pellet (10 mg) releases lymphoid organs are able to regulate intra-organ GCS concen-RU486 at a rate of 500 µg/day. Three days after implantation trations and activities via the actions of a stromal cell-associof pellets the animals were used in subsequent experiments. ated 11β-HSD (23) . It was observed that the immobile stromal GA was administered in vivo as a fine suspension in olive oil cells possess virtually all of the 11β-HSD activity present (100 µl/animal) by i.p. injection. within lymphoid tissues. The specific activity of 11β-HSD in isolated lymphoid organ stroma is significantly greater than Preparation and activation of lymphoid cell suspensions the 11β-HSD activity associated with the total lymphoid organ (23) . Additionally, this enzyme activity was not expressed Spleens were excised and the lymphoid cells were prepared as single cell suspensions in balanced salt solution (BSS). equivalently in all lymphoid organs, with peripheral lymph nodes and spleen containing higher levels of 11β-HSD activity These cell suspensions were washed twice in sterile BSS and cultured at a concentration of 10 7 cells/ml in RPMI 1640 than mucosal draining lymphoid tissues. The enzyme assay was terminated by adding 3 ml of ethyl acetate and vortexing vigorously. The ethyl acetate fraction heat killed L. monocytogenes (HKL) (ATCC #15313) that was prepared as previously described (32) . Splenocyte cultures was removed and evaporated under a stream of nitrogen. The extracts were then redissolved in 25 µl of chloroform:methanol prepared as above were incubated with 10 7 HKL/well.
(9:1) containing 50 µg corticosterone and 11-dehydrocorticosCapture ELISA for quantitation of cytokines terone standards, and spotted onto Silica gel G TLC plates (Analtech, Newark, DE). The plates were developed in chloroThe protocol used to quantify immunoreactive murine IL-2, IL-4, IL-6, IL-10, IFN-γ and TNF-α is according to Schumacher form:methanol (9:1) and the bands containing corticosterone or 11-dehydrocorticosterone were localized by iodine vapor, et al. (33) , and has been previously described in detail by us (34) .
scraped and transferred to scintillation vials. The radioactivity associated with the corticosterone and 11-dehydrocorticos-RT-PCR for the identification of cytokine mRNA terone bands was determined. 11β-HSD activity is expressed as the percent conversion of corticosterone to 11-dehydro-RNA was prepared as previously described (35). Reverse transcription was performed using 5 µg/ml total RNA in a corticosterone. 50 µl reaction mixture containing 10 mM DTT, 1ϫRT buffer Host response to Listeria infection (Gibco/BRL, Gaithersburg, MD), 0.125 mM each of the four deoxyribonucleotide triphosphates, 0.5 µg of random primers
The response to Listeria infection was determined according (New England Biolabs, Beverly, MA), and 400 U M-MLV to the protocol outlined by Cheers et al. (38) . Briefly, normal reverse transcriptase (Gibco/BRL). PCR reactions were C3H strain mice were given either dexamethasone (50 µg) or carried out as outlined recently by Spencer et al. (36) . The GA (2 mg), an inhibitor of 11β-HSD activity, 1 h prior to and primers used in these analysis are as follows: β-actin: 5Ј- 
Serum corticosterone analysis
Statistical analysis Serum samples were obtained from animals that were housed under a 12 h light-12 h dark cycle. Sample collection was
The data is represented as the mean Ϯ SD of multiple performed between 09:00 and 10:00 h to avoid diurnal determinations from an experiment. The data presented in variations in circulating corticosterone levels. Serum corticoseach figure is representative of at least three separate experiterone levels were quantitated by a radioimmunoassay kit ments. Statistical significance was determined by the (ICN Biomedicals, Costa Mesa, CA) according to the manufacStudent's t-test when two data sets were analyzed or, alternatturer's directions. ively, by ANOVA followed with by the appropriate post-hoc test for multiple data sets with the statistical software Statview 11β-HSD assay (version 4.01). The spleens from normal mice injected with vehicle alone or different amounts of GA were removed and snap frozen.
Results Thawed tissues were homogenized in~5 vol. of 0.25 M sucrose in 0.01 M sodium phosphate buffer, pH 7.0 with a GCS effects on cytokine production influences host susceptiTissue-Tearor (Biospec Products, Bartlesville, OK). Determinbility to Listeria infection ing the level of 11β-HSD activity in lymphoid tissue homogenates was performed according to the method of Marandici We have previously demonstrated that the production of type 1 and type 2 cytokines by murine lymphocytes can be and Monder (37) . Homogenates were centrifuged at 105,000 g for 90 min. The pellets were washed with 0.1 M sodium differentially regulated following activation in the presence of varying concentrations of corticosterone (23) . The presence phosphate buffer (pH 7.4) and solubilized by a second homogenization with 0.2% Triton DF-16 in 0.1 M sodium of corticosterone at physiological levels normally present in the circulation under non-stress conditions (~10 -8 M corticosphosphate buffer (pH 7.4). The concentration of protein in the homogenate was determined colorimetrically (BioRad, terone) causes a shift in activated naive lymphocyte production from the type 1 cytokines to predominantly the type 2 Richmond, CA) with BSA dissolved in 0.2% Triton DF-16 buffer as the standard. The homogenates were then adjusted cytokines (Fig. 1A) . This enhancement of lymphocyte IL-4 production by GCS appears to be regulated at the level of to a concentration of 2.5 mg/ml. Enzyme assay tubes were prepared by incubating 840 µl 0.1 M Tris (pH 8.5), 5 nmol transcription, since IL-4 mRNA is increased in cells activated in the presence of low levels of added corticosterone (Fig. 1B) . Similar concentrations of corticosterone greatly reduce the level of IFN-γ mRNA expressed by lymphocytes in response to stimulation. In all of our cell culture systems, serumfree conditions have been used to exclude the effects of exogenous steroids and other substances capable of modulating lymphocyte function (34) . It has been reported by others that exposure to HKL induces the production of the inflammatory (TNF-α, IL-6, IFN-γ and IL-12 p40) and anti-inflammatory (IL-10) cytokines by murine splenocytes (9,32). All of these cytokines have been demon-strated to represent important modulators of host responsiveness of Listeria infection (6,12). We, therefore, questioned the effects that physiological concentrations of GCS would have on the induced production of TNF-α, IL-6, IFN-γ, IL-12 and IL-10 by murine splenocytes in response to stimulation with HKL. The data ( Fig. 2A and B) demonstrate that spleen cells incubated in the presence of HKL and corticosterone produced significantly less TNF-α, IL-6, IFN-γ and IL-12 (Ͼ90% inhibition at 10 -7 M) than similar preparations of cells stimulated with HKL in the absence of added GCS. The induced production of TNF-α by HKL was highly sensitive to the effects of GCS, evidenced by the Ͼ50% inhibition at 10 -9 M corticosterone. An analysis of IL-12 p40 mRNA by RT-PCR (Fig. 2B) determined HKL-induced IL-12 mRNA expression was also inhibited by corticosterone exposure. Even at the lowest corticosterone level used (10 -9 M), HKL induction of splenocyte IL-12 p40 mRNA was significantly depressed. The HKL-induced production of IL-10, however, was significantly enhanced in cultures containing low doses of corticosterone (247% at 10 -8 M) and was not inhibited at 10 -7 M corticosterone.
Based on the ability of GCS to inhibit the production of those cytokines important for controlling Listeria growth in vivo, plus the enhancing effect of GCS on the induction of IL-10 by HKL, we questioned whether the in vivo administration of a moderate dose of the synthetic GCS dexamethasone could alter host susceptibility to Listeria infection. Dexamethasone was utilized since it is poorly metabolized by 11β-HSD in vivo (27) . Treatment of C3H mice in vivo with only 50 µg of dexamethasone 2 h prior to bacterial challenge resulted in an enhanced susceptibility to a Listeria infection compared to control animals treated with vehicle alone. Over a 3 day mice exhibited a significant loss of body weight compared to on day 0 and day 1. Animal weights were determined daily (A). Liver control mice (Fig. 3A) . When sacrificed, the GCS-treated and spleens were removed, and c.f.u. Listeria per gram of tissue animals also had Ͼ10,000 times the bacterial load per gram was determined (B). * P Ͻ 0.005 for weight loss or c.f.u. per gram of liver and spleen than their control counterparts (Fig. 3B) .
of organ from dexamethasone-treated, Listeria-infected C3H mice compared to Listeria-infected C3H strain animals. DexamethasoneInhibition of 11β-HSD activity in vivo allows endogenous GCS treated C3H animals in the absence of a Listeria challenge exhibited no weight loss or bacterial c.f.u. in the spleen and liver (data to negatively influence the production of cytokines critical for not shown).
innate anti-Listeria responses and increases host susceptibility to Listeria infection
We have recently demonstrated that the activities of endogenous circulating GCS on lymphoid cells can be regulated in a tissue-specific manner via the actions of 11β-HSD (23).
A well-characterized competitive inhibitor of 11β-HSD, GA, has been used in vivo to depress the rate of GCS catabolism in 11β-HSD-containing tissues, including the various secondary lymphoid organs (23, 37) . GA, a specific competitive inhibitor (K i~8 nM in rat liver) of 11β-HSD, has been used extensively 5 mg GA i.p., spleen 11β-HSD activity was inhibited by 41
were incubated for 4 h in the presence of different concentrations and 88% respectively (Fig. 4A) . The inhibition of 11β-HSD corticosterone (10 -9 to 10 -6 M). The spleen cell cultures were then activity with GA in vivo was not associated with increased stimulated with HKL (10 7 bacteria per well). After 48 h, culture levels of circulating GCS (Fig. 4B) . Serum taken from C3H systemic administration of GA (39). The RU486 treatment Fig. 4 . Inhibition of lymphoid organ 11β-HSD activity with GA treatment results in the production of predominantly a type 2 cytokine response following lymphocyte activation without significantly altering circulating corticosterone levels. C3H mice were injected with vehicle, 1 mg GA or 5 mg GA. Five hours later, spleens were removed and analyzed for 11β-HSD activity (A) ( * P Ͻ 0.05 for the 11β-HSD activity of spleens from GA-treated mice compared to controls). Serum collected from control, GA-treated (5 mg), RU486-treated, or RU486 plus GA-treated groups was analyzed by a specific RIA to determine corticosterone levels (B). Control or RU486-treated C3H animals were injected i.p. with 5 mg GA or vehicle alone. After 5 h, single cell suspensions were prepared from spleens and were activated (1ϫ10 7 cells/ml) with anti-CD3ε. Culture supernatants were collected after a 24 h incubation period and analyzed for cytokine content by ELISA (C). * P Ͻ 0.05 for cytokine levels from T cells removed from GA-, RU486-or GA plus RU486-treated animals compared to T cells from normal C3H strain animals.
protocol utilized in this and subsequent experiments appears cytokines by lymphocytes residing in secondary lymphoid organs following activation (23) . It is conceivable that the to be effective at blocking GCS receptor activation in vivo since its administration to normal animals results in an increase administration of GA in vivo has secondary effects that can influence resident lymphocyte cytokine production by in circulating GCS levels (Fig. 4B) . Inhibiting endogenous GCS receptor activation with RU486 increases circulating mechanisms other than through its ability to regulate tissuespecific GCS levels. To establish that the effects mediated corticosterone concentrations by blocking the GCS receptormediated negative feedback mechanisms of the hypothalby GA treatment are being caused by elevated endogenous GCS influences, control animals or animals treated with the amic-pituitary axis. It was also determined that RU486, at the dose utilized, had no effect on lymphoid organ 11β-HSD potent GCS-receptor antagonist RU486 were injected i.p. with 5 mg of GA. Five hours later, single cell suspensions were activity (data not shown).
We recently demonstrated that functional inhibition of 11β-prepared from the spleens of treated and vehicle control animals, and stimulated in vitro with anti-CD3ε. As previously HSD activity in vivo with GA depresses the production of the type 1 cytokines and enhances the production of the type 2 reported (23), spleen cells from GA-treated mice exhibited a decrease in the amount of IL-2 and IFN-γ produced following activation, with an 85% inhibition of IFN-γ levels (Fig. 4C) . Conversely, activated splenocytes from animals receiving GA produced greater quantities of type 2 cytokines (225 and 240% for IL-4 and IL-10 respectively). The ability of GA to modulate cytokine production appears to be mediated via a GCS-specific effect since cytokine production by GCSinsensitive lymphocytes from the RU486-treated animals was not influenced by GA administration. RU486 treatment alone slightly, although significantly, elevated activated spleen cell production of both IL-2 and IFN-γ. We next questioned whether an inhibition of 11β-HSD activity in vivo would cause lymphoid organ concentrations of biologically active GCS to rise and modulate the production of cytokines capable of influencing anti-Listeria responses. Groups of normal C3H mice treated with either 50 µg dexamethasone or 2 mg GA were injected i.v. with Listeria (5ϫ10 6 c.f.u./animal). The animals were sacrificed 18 h later and their spleen cells cultured in vitro under serum-free conditions for 8 h. Supernatants were then collected and analyzed for the presence of IFN-γ and IL-10. The data (Fig. 5A) shows that spleen cells from Listeria-infected mice produce significant quantities of IFN-γ. Listeria-infected mice treated with either dexamethasone or GA produce lower levels of IFN-γ (95 and 76% inhibition respectively) compared to control infected animals. In contrast to IFN-γ, IL-10 production by cultured spleen cells removed from infected mice treated with either dexamethasone or GA was significantly elevated (236 and 406% increase respectively) relative to control animals (Fig. 5B) . Similar to uninfected controls, dexamethasone or GA treatment of mice in the absence Listeria infection did not plasma GCS levels and would translate into an enhanced susceptibility of normally resistant animals to Listeria challenge. To test this hypothesis, groups of C3H strain mice with or without RU486 pellets were treated with GA (2 mg) to tissues, as demonstrated by shifts in the types of cytokines produced by activated lymphocytes and macrophages, and temporarily inhibit endogenous 11β-HSD activity. Treated and control groups of animals were then infected with 2ϫ10 4 c.f.u.
an enhanced susceptibility to certain infectious agents. of Listeria. The GA-treated animals were found to lose weight over the 3 day period following Listeria challenge when Discussion compared to vehicle-treated animals (Fig. 6A) . Additionally, the number of bacteria per gram of liver and spleen in the The biochemical activities that result from the activation of members of the steroid hormone receptor superfamily are GA-treated animals was greater than 4 logs higher in the control mice (Fig. 6B) . The increased susceptibility to a quite varied and can affect a multitude of physiological processes in either a positive or negative manner. To control Listeria infection following GA administration was prevented by pretreating the animals with RU486. The inhibition of GA this diversity in cellular responsiveness, mammals and other higher organisms have evolved complex mechanisms which effects with RU486 indicate that the ability of GA to reduce resistance to infection is mediated through the actions of allow them to tightly regulate organ, tissue and intracellular levels of specific steroid hormones in ways that are independ-GCS. These results strongly suggest that 11β-HSD functions as an important regulator of endogenous GCS concentrations ent of circulating hormone concentrations. Some steroids present within the circulation are actually within various lymphoid tissues. Depressions in 11β-HSD activity in vivo results in enhanced GCS influences in affected precursors of the most bioactive forms of the hormone. Following transport via the circulation to tissues were their mechanisms which function to facilitate their conversion to biologically inactive substances. The enzyme 11β-HSD is activities are required for optimum function, these precursors can be enzymatically converted to forms which possess the central to this end-organ catabolic process (27) . Site-specific catabolism of GCS via an enzymatic conversion to their capacity to associate with the cognate steroid hormone receptor and alter cellular processes. For example, the androbio-inactive 11-keto metabolites provides a mechanism for independence between plasma and tissue concentrations of genic effects of circulating testosterone are very weak compared to its 5α-dihydro metabolite dihydrotestosterone (40). these steroids. Further, due to the existence of end organ catabolism, simple measurements of plasma GCS levels Tissues like the prostate express the enzyme 5α-reductase (41). This enzyme allows tissue-specific end-organ metabolcannot translate to an appreciation of tissue-specific GCS activities. ism of testosterone to dihydrotestosterone providing sufficient levels of biologically active androgen to regulate prostate
In the present study, we demonstrate that the active catabolism of endogenous GCS by 11β-HSD takes place within growth and differentiation. Many other steroids are known to circulate as precursors that are converted via cellular enzymes lymphoid organs. This enzymatic activity is required to allow the development of the innate defense responses required to more potent forms in a tissue-specific manner. These include vitamin D 3 , the retinoids and dehydroepiandrosterone for controlling the growth of Listeria in vivo. Physiological concentrations of GCS were found to inhibit the ability of HKL sulfate (42) (43) (44) .
In contrast, the GCS are synthesized and secreted in to to induce spleen cell production of TNF-α, IL-6, IFN-γ and IL-12 in vitro. The quantitative levels of IL-10 from these same the circulation as biologically active hormones. The tissuespecific bioactivities of these steroids are regulated through cultures was enhanced by GCS addition. Inhibition of 11β-HSD activity in vivo by treating animals with a competitive ance to Listeria may be partially due to indirect effects such as an increase in the production of the anti-inflammatory cytokine inhibitor of enzyme activity prior to an experimental Listeria infection resulted in reduced lymphoid cell production of IFN-IL-10. Fluctuations in the levels of endogenous GCS within specific γ and an increase in the production of IL-10. These alterations in Listeria-induced cytokine production, caused by inhibiting target tissues could also influence host responses to Listeria infection. Circulating levels of endogenous corticosteroids are the endogenous catabolism of GCS in vivo, was found to correlate with a significant increase in host susceptibility to controlled via the hypothalamic and pituitary derived factors corticotrophin releasing hormone and adrenocorticotrophic this pathogen. Normal mice treated with 11β-HSD inhibitors were rendered incapable of controlling the progressive growth hormone respectively (26) . Plasma GCS levels can also be influenced by inflammatory cytokines and by GCS themselves of Listeria following infection. Based on these observations, we conclude that the 11β-HSD isoform(s) within peripheral (26) . Recently, it was demonstrated conclusively that target tissue-specific mechanisms exist to control the rates of organ lymphoid organs like the spleen are catabolizing endogenous GCS and lowering tissue concentrations of active corticosterospecific GCS catabolism. 11β-HSD represents a key enzymatic component of this process and serves to tightly regulate GCS ids. Lower GCS levels allow the induced production of the early pro-inflammatory and type 1 lymphocyte responses levels within various organs systems including the kidney, intestine, skin, testes, and lymphoid organs (27) . Under condiwithin these secondary lymphoid organs necessary to effectively control the progression of bacterial growth.
tions of a restricted cellular expression of 11β-HSD, cells residing in different anatomical locations within a single organ or Treatment of animals with the 11β-HSD inhibitor GA or the synthetic GCS dexamethasone resulted in a significant tissue can also vary greatly in intracellular GCS concentrations (47,48). increase in the bacterial burden in both the liver and spleen. Animals treated directly with GCS or with an 11β-HSD inhibitor
We have previously demonstrated the presence of 11β-HSD within lymphoid organs (23) . Enzyme activity is solely restricted exhibited weight loss beginning at day 2 to day 3, a phenomenon that is mediated through the actions of the inflammatory to the stromal elements of the lymphoid tissue (23) . The 11β-HSD present in these tissues possessed characteristics that cytokines such as TNF-α. This is somewhat paradoxical since GCS are known to inhibit the production of the inflammatory distinguish it from either of the presently characterized 11β-HSD enzyme isoforms, suggesting the existence of an addicytokines which would result in cachexia. The observed weight loss in mice infected with Listeria after treatment with GCS or tional isoform of this enzyme (29, 30) . The enzyme activity within secondary lymphoid organs appears to regulate endogenous an inhibitor of 11β-HSD activity might be due to the timing of the treatments. In our experimental system, the treatments GCS influences on resident lymphocyte function, as the inhibition of enzyme activity in vivo resulted in the reduced capacity occur during the first 24 h of infection. It may be that after the effective concentration of GA or dexamethasone has dropped, of resident T cells to produce the type 1 cytokines and enhanced their production of the type 2 cytokines following the high number of Listeria are able to induce large quantities of the cytokines that are involved in weight loss. Alternatively, activation (23) . This inhibition of type 1 cytokine production correlated with depressions in the generation of contact hyperthe observed weight loss in GA-or dexamethasone-treated mice infected with Listeria could be due to a mechanism that sensitivity responses, an immune effector response that is dependent upon the actions of the type 1 cytokines (49) . Similar has yet to be defined.
GCS are known to affect many of the parameters that are results were observed in the present study. Inhibition of lymphoid organ 11β-HSD activity resulted in a similar effect on critical for the optimal function of a hosts' anti-Listeria defense systems. GCS can directly inhibit processes important in baclymphocyte production of GCS regulatable cytokines. Additionally, in vivo administration of the GCS receptor antagonist tericidal activity, such as the production of NO and synthesis of the inflammatory cytokines involved in inducing anti-microbial RU486 prevented GA from influencing lymphocyte cytokine production. defense mechanisms (19). The cytokines important in these innate processes that are inhibited by GCS influences include
The inhibition of 11β-HSD activity by pharmacological means in vivo determined that reductions in the capacity of enzyme IL-1, IL-6, IL-12, TNF-α and IFN-γ (15-18). GCS can also inhibit the production of the antigen induced type 1 cytokines IL-2 containing tissues to effectively catabolize GCS can have dramatic effects on immune function. It is conceivable, therefore, and IFN-γ by activated T cells (18,45). T cell IFN-γ has been demonstrated to be necessary for antigen-specific T cell clearthat any natural or pathological process that results in changes in 11β-HSD activity in lymphoid and other tissues would ance of Listeria (46) .
In addition to the inhibitory actions on inflammatory increase microenvironmental concentrations of GCS in affected sites such that host immune responsiveness would be responses and type 1 T cell cytokine production, GCS actually increase the production of some cytokines that possess potent altered. A depression in 11β-HSD specific activity was found to occur within the lymphoid organs from aged mice when anti-inflammatory activities. Cytokines whose production are enhanced by GCS include IL-4 IL-10, IL-13, transforming compared to similar lymphoid organs of normal mature adult animals (data not shown). This age-associated depression in growth factor-β and lipocortin (20, 21, 23, 24) . Results from the present study demonstrate that stimulation of lymphoid cells lymphoid organ 11β-HSD activity might be partially responsible for the well documented increase in the susceptibility of aged with Listeria in the presence of low GCS concentrations results in an enhanced production of IL-10. Kelly and co-workers have experimental animals and humans to progressive disease resulting from infection by pathogenic microorganisms (50) . recently shown that this cytokine antagonizes host innate defense mechanisms responsible for limiting the spread of Increased tissue concentrations of GCS, resulting from a reduction in tissue-specific corticosteroid catabolism, could occur Listeria in vivo (25) . The ability of GCS to depress host resist-parasites by T cells and T cell-derived cytokines. Annu. Rev.
in vivo without any apparent changes in plasma GCS levels.
Immunol. 10:385. Since optimum physiological function of many tissues is abso-
